NYU Langone Insights on Psychiatry

NYU Langone Health Department of Psychiatry
  • 0.0 (0)
  • LIFE SCIENCES
  • EVERY TWO WEEKS

A podcast for clinicians about the latest psychiatric research. Host Thea Gallagher, PsyD, of NYU Langone Health interviews world-leading researchers about advances in their respective fields, gaining insights that clinicians can apply today.

  1. The Next Big Breakthrough

    21 MAY

    The Next Big Breakthrough

    What if mental health care worked more like cancer treatment—tailored to the individual, informed by biology, and driven by data? Charles Marmar, MD, Chair of Psychiatry at NYU Grossman School of Medicine, takes us through the latest advances in precision psychiatry. From brain imaging to digital phenotyping, Dr. Marmar outlines the tools shaping a future where treatment is fully customized. He also shares stories from the front lines: a patient whose depression was treated with the help of a brain biopsy, why PTSD and depression aren’t one-size-fits-all, and how quantum computing could radically accelerate psychiatric research. 🔍 Topics Covered 00:00 Introduction 02:24 Personalized Treatment Approaches 05:13 Challenges in Precision Psychiatry 11:12 The Role of Genomics and Brain Imaging 23:35 Digital Psychiatry and AI 25:57 Quantum Computing in Psychiatry 33:04 Future of Precision Psychiatry 37:22 Conclusion 📚 Related Resources Charles Marmar, MD – NYU Faculty Profile NYU Langone Psychiatry Adriana Heguy, PhD – NYU Faculty Profile Javad Shabani, PhD – NYU Faculty Profile 🙌 Support & Subscribe If this episode challenged your thinking, like, share, and subscribe to help bring smart, science-forward conversations to a wider audience. Visit our website for more Insights on Psychiatry. Watch this episode on YouTube Executive Producer: Jon Earle

    44 min
  2. The Schizophrenia Puzzle is Solvable

    14 MAY

    The Schizophrenia Puzzle is Solvable

    There’s a care model for schizophrenia that actually works—why isn’t it everywhere? On this episode, W. Gordon Frankle, MD, MBA, Vice Chair of Psychiatry at NYU Langone Health, shares how his team in Brooklyn is building a new model for treating serious mental illness—one rooted in long-term, relationship-driven, team-based care. From wraparound services to precision psychiatry, this conversation explores what happens when you bring humanity, structure, and innovation to a population too often left behind. Also discussed: The first novel schizophrenia drug in over 50 years (Cobenfy)Why clozapine is underused—and how that may finally changeThe potential of brain imaging and biomarkers in psychiatric treatmentWhat a real community mental health system looks likeWhy trust, not just treatment, is essential for recovery🔍 Topics Covered 00:00 Introduction 00:30 Dr. Frankle's Current Work 01:08 Advancements in Schizophrenia Research 02:29 Challenges and New Treatments in Schizophrenia 05:02 Precision Medicine in Psychiatry 05:59 PET Scans and Brain Energetics 09:46 Barriers to Effective Treatment 11:51 Clozapine and Treatment Access 13:38 Wraparound Services and Community Care 14:46 Early Screening and Public Health Interventions 18:32 Mandated Treatment and Patient Engagement 30:08 Homelessness and Mental Health 34:54 Future Directions in Schizophrenia Treatment 38:09 Conclusion 📚 Related Resources W. Gordon Frankle, MD, MBA Schizophrenia care at NYU Langone NYU Langone Hospital—Brooklyn 3 Things to Know About Cobenfy (Yale Medicine) 🙌 Support & Engage If you enjoyed this episode, please like, share, and subscribe to support real conversations about transforming mental health care. Visit our website for more Insights on Psychiatry. Watch this episode on YouTube Executive Producer: Jon Earle

    39 min
  3. How Psychedelics Rewire the Brain

    7 MAY

    How Psychedelics Rewire the Brain

    How could a single psychedelic treatment cause lasting change? Joshua Siegel, MD, PhD, is on a mission to find out. A leading expert on neuroimaging and neuropsychopharmacology at NYU Langone’s Center for Psychedelic Medicine, Dr. Siegel unpacks how psilocybin may spark neuroplasticity and reshape the depressed brain. He also gives us an inside look at the race to develop non-hallucinogenic psychedelic analogs.  Dr. Siegel is an assistant professor at NYU Grossman School of Medicine. 🔍 Topics Covered: 00:00 Introduction 00:15 Dr. Siegel's Current Work 01:01 Past Research and Human Psilocybin Imaging Study 02:39 Understanding Brain Changes and Biomarkers 06:13 Mechanisms of Action and Plasticity 12:51 Surprising Findings and Context Dependence 16:34 Challenges and Future Directions in Psychedelic Research 20:46 Advanced Imaging and Personalized Treatment Plans 24:15 Setbacks and Lessons in Psychedelic Medicine 28:40 Emerging Areas in Neuropsychopharmacology 31:46 Conclusion 📚 Related Resources: Joshua Siegel, MD, PhD  NYU Langone Health’s Center for Psychedelic Medicine The Multidisciplinary Association for Psychedelic Studies (MAPS) “Psychedelic and Dissociative Drugs as Medicines” (NIH)  🙌 Support & Engage: Enjoyed this episode? Like, comment, and share to support science-based conversations about mental health. 🔔 Don’t forget to subscribe for more interviews with top psychiatric researchers. Visit our website for more Insights on Psychiatry. Watch this episode on YouTube Executive Producer: Jon Earle

    32 min
  4. Can AI Help Prevent PTSD?

    30 APR

    Can AI Help Prevent PTSD?

    What if a simple conversation in the emergency room could reveal who’s most at risk for PTSD before symptoms even begin? Katharina Schultebraucks, PhD, shares her innovative work on using machine learning to forecast mental health outcomes and explains how AI could revolutionize how we detect, prevent, and treat psychiatric disorders. Dr. Schultebraucks is Co-Director of the Computational Psychiatry Program and Associate Professor in the Department of Psychiatry and Population Health at NYU Grossman School of Medicine. 🔍 Topics Covered 00:00 Introduction 00:23 Current Work and Research Focus 01:29 Objective Measures in Psychiatry 02:50 Predicting PTSD Risk 04:28 Early Preventive Interventions 05:47 Machine Learning in Mental Health 09:49 Challenges and Surprises in Research 22:46 Burnout in Emergency Department Providers 27:17 Precision Psychiatry and Future Directions 29:35 Conclusion 📚 Related Resources -Katharina Schultebraucks, PhD -Computational Psychiatry Program in NYU Langone’s Department of Psychiatry -“Dissecting racial bias in an algorithm used to manage the health of populations” by Ziad Obermeyer, et al -PTSD Treatment at NYU Langone Health  🔔 Subscribe for more conversations at the intersection of mental health and innovation. 📢 Like, comment, and share if this episode sparked your thinking. Visit our website for more Insights on Psychiatry. Watch this episode on YouTube Executive Producer: Jon Earle

    30 min
  5. ADHD at School: What Actually Helps

    23 APR

    ADHD at School: What Actually Helps

    How do you help a child with ADHD stay organized, on task, and confident in school? Richard Gallagher, PhD, a child and adolescent psychologist at NYU Langone Health, shares groundbreaking research on organizational skills training for children with ADHD—a behavioral treatment that’s changing lives and improving classroom performance. This episode dives into how executive functioning challenges manifest in real life, the strengths (and limits) of technology, and the power of parent training and therapeutic coaching to help children thrive. Dr. Richard Gallagher is Associate Professor in the Department of Child and Adolescent Psychiatry at NYU Grossman School of Medicine, and Director of the Organization Skills Program. 🔍 Topics Covered 00:00 Introduction 00:19 Current Research on Organizational Skills 01:06 Executive Functioning and Practical Interventions 02:37 Impact of Interventions on ADHD 04:41 Expanding Research and Brain Connectivity 05:08 Medication and Organizational Skills 08:11 Technology in ADHD Assessment 15:39 Effective Parenting Styles for ADHD 23:10 Non-Pharmacological Treatments and Future Research 25:58 Conclusion and Final Thoughts 📚 Related Resources 👨‍⚕️More about Dr. Richard Gallagher 🔬 NYU Child Study Center 📘 “Organizational Skills Training for Children with ADHD” by Richard Gallagher, Howard B. Abikoff, and Elana G. Spira  📝 CHADD Parent Training Resources 📈 CDC ADHD Parent Guide 🙌 Support & Engage If this episode was helpful, please like, share, and subscribe to support the series and spread awareness about evidence-based ADHD care. Visit our website for more Insights on Psychiatry. Watch this episode on YouTube Executive Producer: Jon Earle

    30 min
  6. The Hidden Adult ADHD Crisis

    16 APR

    The Hidden Adult ADHD Crisis

    ADHD isn’t just a childhood condition—many adults go undiagnosed for years. Lenard Adler, MD, Director of the Adult ADHD Program at NYU Langone Health, breaks down the nuances of ADHD in adults, the challenges of proper diagnosis, and the latest treatments available. Learn about his research, the screening tools his team has developed, and what’s on the horizon for adult ADHD care. 🔍 Topics Covered: 00:00 Introduction 00:44 Dr. Adler’s Current Research Focus 01:47 Importance of Proper Assessment 03:44 Challenges in Diagnosing Adult ADHD 06:15 Gender Differences in ADHD Diagnosis 07:51 Impact of ADHD on Lifespan 10:10 Comorbidities and Treatment Approaches 14:54 Medication and Treatment Strategies 21:15 Medication Shortages and Solutions 28:42 Recent Developments in ADHD Research 35:01 Screening and Diagnostic Tools 37:33 Conclusion 📚 Related Resources: Lenard A. Adler, MD (official bio)Adult ADHD Program at NYU Langone HealthAdult Self-Report Scale (ASRS) ScreenerLife expectancy and years of life lost for adults with diagnosed ADHD in the UK: matched cohort study | The British Journal of PsychiatryAmerican Professional Society of ADHD and Related Disorders (APSARD)CHADD: ADHD Resources and Support🙌 Support & Engage: If you found this episode helpful, please like, comment, and share to spread awareness. 🔔 Don’t forget to subscribe to stay updated on new episodes. Visit our website for more Insights on Psychiatry. Watch this episode on YouTube Executive Producer: Jon Earle

    36 min
  7. How to Make Addiction Care Routine

    9 APR

    How to Make Addiction Care Routine

    Despite affecting more Americans than diabetes, substance use is often left out of routine medical care. In this episode, NYU Langone Health’s Jennifer McNeely, MD—a clinician investigator, primary care and addiction medicine physician—explains why that must change. From the surprising history behind addiction’s exclusion from mainstream medicine to the innovative screening tools shaping the future of care, this conversation is a must-listen for anyone interested in addiction care and healthcare policy. Jennifer McNeely, MD, is an Associate Professor of Medicine and Population Health at NYU Grossman School of Medicine and co-director of the Section on Tobacco, Alcohol, and Drug Use. 🔍 Topics Covered: 00:00 – Introduction 01:15 – Why addiction hasn’t been part of traditional medical care 05:00 – What medications can primary care providers actually prescribe? 07:00 – Why lifting legal barriers isn’t enough 08:00 – Making substance use screening part of routine care 11:50 – The power of self-report screening tools 13:30 – What primary care physicians can actually do after screening 16:10 – Real-world clinical impact of identifying substance use 18:00 – Overcoming stigma and “we don’t do that here” culture 22:17 – Can AI help with screening and care prioritization? 📚 Related Resources: Jennifer McNeely, MD Addiction Treatment at NYU Langone NIDA’s Resources for Clinicians Substance Use Screening Tools (NIDA) 🙌 Support & Engage: If you found this episode helpful, please like, comment, and share to spread awareness. 🔔 Don’t forget to subscribe to stay updated on new episodes. Visit our website for more Insights on Psychiatry. Watch this episode on YouTube Executive Producer: Jon Earle

    29 min
  8. The Key to Effective Addiction Care

    2 APR

    The Key to Effective Addiction Care

    What makes addiction treatment truly effective? Behavioral scientist Charles Neighbors, MBA, PhD, shares groundbreaking research on the importance of therapeutic relationships, harm reduction, and human connection—love!—in treating substance use disorders. Dr. Neighbors is an Associate Professor in the Departments of Population Health, and Psychiatry at NYU Grossman School of Medicine. 💡 Topics Covered 00:00 Introduction to Dr. Charles Neighbors 01:37 The biggest challenges in addiction treatment 02:24 The Importance of Therapeutic Relationships 05:59 Defining “good treatment” and why love matters 08:05 The role of therapeutic alliance in patient outcomes 14:06 Barriers to change in addiction treatment systems (incl. stigma) 22:04 Harm reduction and safe injection sites: What does the science say? 30:36 Future directions in addiction policy and treatment 📚 Related Resources Charles J. Neighbors, MBA, PhD (official bio)Dr. Neighbors’ Lab - Health Evaluation & Analytics Lab (HEAL)Addiction Treatment at NYU LangoneUnderstanding Harm Reduction: National Institute on Drug Abuse (NIDA)"Motivational Interviewing" by William R. Miller and Stephen RollnickCommunity Reinforcement and Family Training (CRAFT)SAMHSA’s National Helpline for Mental Health, Drug, Alcohol IssuesNew York State Office of Addiction Services and Supports (OASAS)🔔 Subscribe for more insights on mental health & addiction treatment! 👍 If you found this video helpful, please like, comment, and share to spread awareness! Visit our website for more Insights on Psychiatry. Watch this episode on YouTube Executive Producer: Jon Earle

    34 min
See All (33)

About

A podcast for clinicians about the latest psychiatric research. Host Thea Gallagher, PsyD, of NYU Langone Health interviews world-leading researchers about advances in their respective fields, gaining insights that clinicians can apply today.

Information

  • Creator
    NYU Langone Health Department of Psychiatry
  • Years Active
    2023 - 2025
  • Episodes
    33
  • Rating
    Clean
  • Copyright
    © 2025 NYU Langone Health
  • Show Website
    NYU Langone Insights on Psychiatry

You Might Also Like